| Name | Title | Contact Details |
|---|
In July 2014, Genoa Healthcare and QoL meds combined to create Genoa, a QoL Healthcare Company, the nation`s leading behavioral health specialty pharmacy company. This merger brought together two pharmacy organizations with proven track records for excellent service to individuals with mental illness. Both companies had strong reputations for outstanding customer service, flexibility and delivering true value to their consumers and partners. By uniting their strengths – like best practices and expertise – the combined company was able to better serve individuals and the health organizations that care for them over the past year. Genoa has been serving the behavioral health community for over 15 years. The company now provides specialty behavioral health and long-term care pharmacy services to more than 500,000 individuals annually, operating over 285 pharmacies in 39 states and the District of Columbia and filling more than 9 million prescriptions per year. Although Genoa specializes in serving behavioral health consumers, we are a full-service pharmacy. This means we take care of all the medication needs of our consumers, including prescriptions written by psychiatrists, primary care providers, or other specialty prescribers. Genoa remains flexible to the many behavioral health and primary care delivery models across the country and developed services within our pharmacies to meet the needs of those specific models. None of our service models or pharmacies are the same. We take pride in not being a "cookie cutter" organization, and continue to seek opportunities nationwide to help behavioral health communities with their pharmacy services.
Pathology Service Associates, LLC is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Pathology Service Associates, LLC is based in Florence, SC. You can find more information on Pathology Service Associates, LLC at www.psapath.com
Memphis Center for Independent Living is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
iWalk is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Alliance Physical Therapy Partners is the 7th largest physical therapy provider in the U.S., with more than 70 outpatient PT locations nationwide. The company was founded by patient-focused healthcare experts who were seeking to transform the traditional healthcare experience by infusing innovation and passion so that more people can enjoy the benefits of physical therapy. Alliance Physical Therapy Partners is also the parent company of Work-Fit, an injury prevention solutions provider who applies sports medicine techniques in the workplace to prevent injuries. In addition, BioCorrect Custom Orthotics Lab is part of the Alliance Physical Therapy Partner brands, providing a patented foot alignment system, evaluation process, and innovative custom and semi-custom foot orthotics for competitive athletics, outdoor recreation or people just living life to the fullest. Alliance Physical Therapy Partners is an affiliate of GPB Capital Holdings, LLC focused on acquiring private physical therapy practices across the U.S. to provide practice owners the opportunity to expand their footprint while receiving operational guidance and financial support. The Alliance team includes former private practice owners, direct marketing professionals and operations experts who have experience running and growing successful healthcare organizations. About GPB Capital Holdings, LLC GPB Capital is a New York-based alternative asset management firm focusing on acquiring income-producing private companies. GPB Capital seeks to provide its portfolio companies with the strategic planning, managerial insight, and capital needed to enable strong businesses to achieve the next level of growth and profitability. GPB Capital has over $1.5 billion in assets under management[i] and has acquired or invested in more than 160 portfolio companies. For more information, please visit www.gpb-cap.com. [i] Which is different and distinct from GPB Capital`s “Regulatory AUM.”